The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4642
Abstract: The role of neoadjuvant chemotherapy (NACT) and primary debulking surgery (PDS) in advanced epithelial ovarian cancer (EOC) remains controversial. This study aimed to investigate the prognosis between NACT and PDS in advanced EOC. We also… read more here.
Keywords: neoadjuvant chemotherapy; epithelial ovarian; advanced epithelial; primary debulking ... See more keywords
Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25187
Abstract: The optimum treatment strategy for patients with unresectable advanced epithelial ovarian cancer is controversial. This study examined bevacizumab combined with neoadjuvant chemotherapy (NAC; paclitaxel plus carboplatin), followed by interval debulking surgery (IDS), for these patients. read more here.
Keywords: epithelial ovarian; advanced epithelial; ovarian cancer; neoadjuvant chemotherapy ... See more keywords
Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Abdominal Radiology"
DOI: 10.1007/s00261-019-02175-0
Abstract: Purpose To provide an overview for radiologists of the systemic agents used in the treatment of advanced epithelial ovarian cancer (EOC) and their associated toxicities. Results EOC is a common gynecological malignancy, with the majority… read more here.
Keywords: systemic therapies; epithelial ovarian; treatment advanced; advanced epithelial ... See more keywords
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01567-y
Abstract: Background The purpose of this study was to determine the optimal regimen of neoadjuvant chemotherapy (NAC) for advanced epithelial ovarian, fallopian tube, and peritoneal cancers. Methods A clinical information survey involving 171 patients with advanced… read more here.
Keywords: paclitaxel carboplatin; epithelial ovarian; advanced epithelial; dose dense ... See more keywords
First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Investigational New Drugs"
DOI: 10.1007/s10637-022-01217-7
Abstract: Purpose. Sym013 contains six humanized monoclonal antibodies that bind to non-overlapping epitopes on three human epidermal growth factor receptors (HER1-3). Preclinical studies suggested Sym013 strongly suppresses growth of multiple epithelial tumors. This is a first-in-human… read more here.
Keywords: exploring safety; advanced epithelial; trial; epithelial malignancies ... See more keywords
Correlation of Pattern of Spread and Outcomes in Advanced Epithelial Ovarian Cancers
Sign Up to like & getrecommendations! Published in 2017 at "Indian Journal of Surgical Oncology"
DOI: 10.1007/s13193-017-0618-5
Abstract: The purpose of this study was to correlate the pattern of spread with oncological outcomes in advanced ovarian cancer patients. This is a retrospective analysis of 55 consecutive patients who had advanced epithelial ovarian cancer… read more here.
Keywords: pattern spread; epithelial ovarian; class; advanced epithelial ... See more keywords
Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.07.121
Abstract: OBJECTIVE Evaluate association between baseline quality of life (QOL) and changes in QOL measured by FACT-O TOI with progression-free disease (PFS) and overall survival (OS) in advanced epithelial ovarian cancer (EOC). METHODS Patients enrolled in… read more here.
Keywords: advanced epithelial; toi scores; fact toi; quality life ... See more keywords
Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center.
Sign Up to like & getrecommendations! Published in 2022 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2022.03.023
Abstract: OBJECTIVE To compare survival rates of surgically treated advanced epithelial ovarian cancer patients before and after a programmatic change in surgical approach from standard surgery towards ultra-radical surgery. METHODS 247 patients with FIGO stage IIIB-IV… read more here.
Keywords: advanced epithelial; ovarian cancer; surgery; stage ... See more keywords
288 What is the prognostic value of lymphadenectomy in advanced epithelial ovarian cancer?
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-igcs.288
Abstract: Objectives To evaluate the role of lymphadenectomy in advanced epithelial ovarian cancer (EOC). Methods Data of 121 patients who underwent surgery for FIGO staged IIB-IV EOC between 2000 and 2010 were retrospectively reviewed. Results Primary… read more here.
Keywords: advanced epithelial; ovarian cancer; cancer; lymphadenectomy ... See more keywords
Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Ovarian Research"
DOI: 10.1186/s13048-020-0614-1
Abstract: Objective The aim of this study is to establish a noninvasive preoperative model for predicting primary optimal cytoreduction in advanced epithelial ovarian cancer by HE4 and CA125 combined with clinicopathological parameters. Methods Clinical data including… read more here.
Keywords: primary optimal; preoperative serum; advanced epithelial; model ... See more keywords
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2022.33.e80
Abstract: Objective The current investigation analyzes the prognostic role of the time to chemotherapy (TTC) interval following primary cytoreductive surgery for patients with advanced epithelial ovarian cancer. Methods Characteristics and outcome data for 509 consecutive patients… read more here.
Keywords: epithelial ovarian; advanced epithelial; ovarian cancer; cytoreductive surgery ... See more keywords